These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2855572)

  • 41. Mechanistic modeling of drug release from chitosan coated tablets.
    Koizumi T; Ritthidej GC; Phaechamud T
    J Control Release; 2001 Feb; 70(3):277-84. PubMed ID: 11182198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms.
    Leane MM; Nankervis R; Smith A; Illum L
    Int J Pharm; 2004 Mar; 271(1-2):241-9. PubMed ID: 15129991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of anionic water-soluble dyes on film coating properties of chitosan acetate.
    Ritthidej GC; Phaechamud T
    Drug Dev Ind Pharm; 2003 May; 29(5):585-94. PubMed ID: 12779288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a sustained release dosage form for alpha-lipoic acid. I. Design and in vitro evaluation.
    Bernkop-Schnürch A; Schuhbauer H; Clausen AE; Hanel R
    Drug Dev Ind Pharm; 2004 Jan; 30(1):27-34. PubMed ID: 15000427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate.
    Takayama K; Hirata M; Machida Y; Masada T; Sannan T; Nagai T
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1993-7. PubMed ID: 2268902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation of floating drug delivery system by plasma technique.
    Nakagawa T; Kondo S; Sasai Y; Kuzuya M
    Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):514-8. PubMed ID: 16595955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma prednisolone levels in man following administration in plain and enteric-coated forms.
    Wilson CG; May CS; Paterson JW
    Br J Clin Pharmacol; 1977 Jun; 4(3):351-5. PubMed ID: 901703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a sustained release dosage form for alpha-lipoic acid. II. Evaluation in human volunteers.
    Bernkop-Schnürch A; Reich-Rohrwig E; Marschütz M; Schuhbauer H; Kratzel M
    Drug Dev Ind Pharm; 2004 Jan; 30(1):35-42. PubMed ID: 15000428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dosage form design for improvement of bioavailability of levodopa VI: formulation of effervescent enteric-coated tablets.
    Nishimura K; Sasahara K; Arai M; Nitanai T; Ikegami Y; Morioka T; Nakajima E
    J Pharm Sci; 1984 Jul; 73(7):942-6. PubMed ID: 6088756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of thickness and hardness of the coating film on the drug release rate of theophylline granules coated with chitosan-sodium tripolyphosphate complex.
    Kawashima Y; Handa T; Kasai A; Takenaka H; Lin SY
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2469-74. PubMed ID: 4064205
    [No Abstract]   [Full Text] [Related]  

  • 51. Absorption of enteric and non-enteric coated prednisolone tablets.
    Hulme B; James VH; Rault R
    Br J Clin Pharmacol; 1975 Aug; 2(4):317-20. PubMed ID: 1233990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of the acid type on the physical and drug liberation properties of chitosan-gelatin sponges.
    Leffler CC; Müller BW
    Int J Pharm; 2000 Jan; 194(2):229-37. PubMed ID: 10692647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers.
    Mooren FC; Berthold A; Domschke W; Kreuter J
    Pharm Res; 1998 Jan; 15(1):58-65. PubMed ID: 9487547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Stability of salts for oral rehydration].
    Miritello-Santoro MI; Vernego MJ
    Bol Med Hosp Infant Mex; 1988 Jun; 45(6):407-9. PubMed ID: 2844204
    [No Abstract]   [Full Text] [Related]  

  • 55. Directly compressed tablets containing chitin or chitosan in addition to mannitol.
    Sawayanagl Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1982 Nov; 30(11):4216-8. PubMed ID: 6819894
    [No Abstract]   [Full Text] [Related]  

  • 56. Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits.
    Miyazaki S; Yamaguchi H; Yokouchi C; Takada M; Hou WM
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4033-8. PubMed ID: 3245982
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of chitosan for sustained-release preparations of water-soluble drugs.
    Sawayanagi Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1982 Nov; 30(11):4213-5. PubMed ID: 7165883
    [No Abstract]   [Full Text] [Related]  

  • 58. Quantitative evaluation of pharmaceutical effervescent systems I: Design of testing apparatus.
    Anderson NR; Banker GS; Peck GE
    J Pharm Sci; 1982 Jan; 71(1):3-6. PubMed ID: 6276529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Directly compressed tablets containing chitin or chitosan in addition to lactose or potato starch.
    Sawayanagi Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1982 Aug; 30(8):2935-40. PubMed ID: 7139835
    [No Abstract]   [Full Text] [Related]  

  • 60. Chitinosan-drug complexes: effect of electrolyte on naproxen release in vitro.
    Rege PR; Shukla DJ; Block LH
    Int J Pharm; 2003 Jan; 250(1):259-72. PubMed ID: 12480291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.